MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience ROA Ratio 2011-2026 | VIVO
Annual ROA Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.17 | 15.88 | 11.4 | 7.49 | 9.49 | 8.63 | 12.8 | 19.39 | 19.64 | 21.52 | 20.68 | 17.26 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.52 | 7.49 | 14.44 |
Quarterly ROA Ratio Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.66 | 15.53 | 12.05 | 14.66 | 14.42 | 14.78 | 16.38 | 20.56 | 21.31 | 15.83 | 15.49 | 10.26 | 4.53 | 6.93 | 7.83 | 8.99 | 11.35 | 10.6 | 10.73 | 8.11 | 7.41 | 7.42 | 7.31 | 10.69 | 10.66 | 12.92 | 15.36 | 16.85 | 19.21 | 18.89 | 18.9 | 18.92 | 18.54 | 18.33 | 18.88 | 19.64 | 20.97 | 22.11 | 22.25 | 21.82 | 21.28 | 20.13 | 19.13 | 18.2 | 17.18 | 4.32 | 4.4 | 4.23 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.25 | 4.23 | 14.21 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
3.33 | $ 9.26 | 1.09 % | $ 617 M |  USA |
|
Biodesix
BDSX
|
-44.15 | $ 14.6 | -3.63 % | $ 1.89 B | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 8.45 | 9.74 % | $ 33.7 M |  Israel |
 |
DexCom
DXCM
|
13.19 | $ 66.09 | -1.12 % | $ 25.8 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 103.08 | 3.09 % | $ 8.5 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 573.29 | -0.42 % | $ 46.1 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 124.4 | -1.43 % | $ 19.8 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 466.6 | -0.04 % | $ 13.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.62 | -1.28 % | $ 428 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.52 | 1.98 % | $ 392 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 196.15 | -0.62 % | $ 19.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 165.13 | -0.46 % | $ 8.18 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.17 | -1.68 % | $ 812 M | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.35 | -2.88 % | $ 405 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.59 | 22.4 % | $ 2.46 M | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.32 | -4.94 % | $ 434 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
-0.5 | $ 59.41 | -2.06 % | $ 4.47 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
-37.95 | $ 114.81 | 4.16 % | $ 4.53 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.56 | -2.96 % | $ 274 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 268.38 | 0.89 % | $ 22.3 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 7.76 | -0.13 % | $ 994 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 31.83 | -0.03 % | $ 1.62 B | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-32.34 | $ 27.2 | -0.15 % | $ 35.3 M | USA |